Early and Late De Novo Tumors after Liver Transplantation in Adults: The Late Onset of Bladder Tumors in Men

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Maggi, Umberto ^a,b   Consonni, Dario ^a   Manini, Matteo Angelo ^d   Gatti, Stefano ^a   Cuccaro, Francesco ^c   Donato, Francesca ^d   Conte, Grazia ^a   Bertazzi, Pier Alberto ^a,d   Rossi, Giorgio ^a,d  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Azienda Sanitaria Locale BAT (Barletta Andria Trani)   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLADDER TUMOR; CANCER INCIDENCE; CANCER RISK; FEMALE; FOLLOW UP; HUMAN; ITALY; KAPOSI SARCOMA; LIVER TRANSPLANTATION; LYMPHATIC SYSTEM TUMOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; SCLEROSING CHOLANGITIS; STANDARDIZED INCIDENCE RATIO;

ADULT; AGED; FEMALE; HUMANS; INCIDENCE; ITALY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84878960946     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065238     Document Type: Article

References (34)

1. European Liver Transplant Registry website. Available: www.eltr.org. Accessed 2013 Mar 13.
2. Baccarani U, Piselli P, Serraino D, Adani GL, Lorenzin D, et al. (2010) Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Digestive and Liver Disease 42: 55-60.
3. Åberg F, Pukkala E, Hockerstedt K, Sankila R, Isoniemi H, (2008) Risk of Malignant Neoplasms After Liver Transplantation: A Population-Based Study. Liver Transplantation 14: 1428-1436.
4. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, et al. (2001) Increased cancer risk after liver transplantation: a population-based study. J Hepatol 34: 84-91.
5. Breslow NE, Day NE (1987) Statistical methods in cancer research, Vol. 2. The design and analysis of cohort studies. Lyon: IARC Press.
6. Clayton D, Hills M (1993) Statistical models in epidemiology. New York: Oxford University Press.
7. Lash TL, Cole SR, (2009) Immortal Person-Time in studies of cancer outcomes. Journal of clinical Oncology 27: e55-e56.
8. StataCorp (2009) Stata: Release 11. Statistical Software. College Station, TX: StataCorp LP.
9. Jain A, Patil VP, Fung J, (2008) Incidence of De Novo Cancer and Lymphoproliferative Disorders After Liver Transplantation in Relation to Age and Duration of Follow-Up. Liver Transplantation 14: 1406-1411.
10. Miao Y, Everly JJ, Gross TG, Tevar AD, First MR, et al. (2009) De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation 87: 1347-59.
11. Baccarani U, Adani GL, Serraino D, Lorenzin D, Gambato M, et al. (2009) De Novo Tumors Are a Major Cause of Late Mortality After Orthotopic Liver Transplantation. Transpl Proc. 41: 1303-1305.
12. Aseni P, Vertemati M, De Carlis L, Sansalone CV, Bonacina E, et al. (2006) De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation. Pathology International 56: 712-715.
13. Boin I, Leonardi MI, Stucchi RB, Ataide EC, Almeida JR, et al. (2007) De Novo Posttransplantation Nonlymphoproliferative Malignancies in Liver Transplant Recipient. Transpl Proc 39: 3284-3286.
14. Xiol X, Guardiola J, Menendez S, Lama C, Figueras J, et al. (2001) Risk Factors for Development of De Novo Neoplasia After Liver Transplantation. Liver Transplantation 7: 971-975.
15. Buell JF, Brock GN, (2008) Risk of Cancer in Liver Transplant Recipients: A Look into the Mirror Liver transplantation. 14: 1561-1563.
16. Galve ML, Cuervas-Mons V, Figueras J, Herrero I, Mata M, et al. (1999) Incidence and Outcome of De Novo Malignancies After Liver Transplantation. Transpl. Proc. 31, 1275-1277.
17. Romero-Vargas ME, Flores-Cortes M, Valera Z, Gomez-Bravo MA, Barrera-Pulido L, et al. (2006) Cancers of New Appearance in Liver Transplant Recipients: Incidence and Evolution. Transpl. Proc (38):: 2508-2510.
18. Di Benedetto F, Di Sandro S, De Ruvo N, Berretta M, Masetti M, et al. (2008) Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol 134: 653-658.
19. Collett D, Mumford L, Banner NR, Neubergerd J, Watson C, (2010) Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit. American Journal of Transplantation 10: 1889-1896.
20. Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, et al. (2003) Cancer risk following organ transplantation: a nationwide cohort study in Sweden. British Journal of Cancer 89: 1221-1227.
21. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, et al. (2001) De Novo Malignancies After Liver Transplantation: A Major Cause of Late Death. Liver Transplantation 7: S109-S118.
22. Ben-Eliyahu S, Page GG, Yirminiya R, Taylor AN, (1996) Acute alcohol intoxication suppressed natural killer cell activity and promotes tumor metastasis. Nat Med 2: 457.
23. Lotzovà E, (1993) Definition and functions of natural killer cells. Nat Immun. 12: 169-176.
24. Mather GG, Talcott PA, Exon JH, (1994) Characterisation of a chemically induced tumor model and the effects of natural killer cell depletion by antisialo GM-1. Immunobiology 190: 333-345.
25. Jiménez C, Rodríguez D, Marqués E, Loinaz C, Alonso O, et al. (2002) De novo tumors after orthotopic liver transplantation. Transpl Proc 34: 297-298.
26. Kenngott S, Gerbes AL, Schauer R, Bilzer M, (2003) Rapid development of esophageal squamous cell carcinoma after liver transplantation for alcohol-induced cirrhosis. Traspl Int 16(9): 639-41.
27. Herrero JI, Pardo F, D'Avola D, Alegre F, Rotellar F, et al. (2011) Risk Factors of Lung, Head and Neck, Esophageal, and Kidney and Urinary TractCarcinomas After Liver Transplantation: The Effect of Smoking Withdrawal. Liver Transplantation 17: 402-408.
28. Jiménez-Romero C, Manrique Municio A, Marqués Medina E, Colina F, Ortega Domene P, et al. (2006) Incidence of De Novo Nonmelanoma Skin Tumors After Liver Transplantation for Alcoholic and Nonalcoholic Liver Diseases. Transpl Proc 38: 2505-2507.
29. Jimenez C, Manrique A, Marques E, Ortega P, Loinaz C, et al. (2007) Incidence and risk factors for the development of lung tumors after liver transplantation. Transpl Int 20: 57-63.
30. Delcò F, Müllhaupt B, (2006) Should we screen for colorectal cancer in liver transplantation? J Hepatol. 44(1): 32-8.
31. Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, et al. (2003) Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 120: 211-216.
32. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, et al. (2005) Incidence of Cancers Following Orthotopic Liver Transplantation in a Single Center: Comparison with National Cancer Incidence Rates for England and Wales. Transplantation 80: 759-764.
33. Sanchez W, Talwalkar JA, Gores GJ, (2006) Will all liver transplantation patients eventually die from cancer? Journal of Hepatology 44: 13-38.
34. Yao FY, Gautam M, Palese C, Rebres R, Terrault N, et al. (2006) De novo malignancies following liver transplantation: a case- control study with long-term follow-up. Clin Transplant 20: 617-623.